Exact Mass: 410.0354744
Exact Mass Matches: 410.0354744
Found 96 metabolites which its exact mass value is equals to given mass value 410.0354744,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Butoconazole
C19H17Cl3N2S (410.0177972000001)
Butoconazole is only found in individuals that have used or taken this drug. It is an imidazole antifungal used in gynecology.The exact mechanism of the antifungal action of butoconazole is unknown, however, it is presumed to function as other imidazole derivatives via inhibition of steroid synthesis. Imidazoles generally inhibit the conversion of lanosterol to ergosterol via the inhibition of the enzyme cytochrome P450 14α-demethylase, resulting in a change in fungal cell membrane lipid composition. This structural change alters cell permeability and, ultimately, results in the osmotic disruption or growth inhibition of the fungal cell. G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AF - Imidazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
Ceftibuten
Ceftibuten is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic. It is an orally-administered agent. Cefalexin is used to treat acute bacterial exacerbations of chronic bronchitis (ABECB), acute bacterial otitis media, pharyngitis, and tonsilitis.Ceftibuten exerts its bactericidal action by binding to essential target proteins of the bacterial cell wall. This binding leads to inhibition of cell-wall synthesis. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
(Acetyloxy)triphenylstannane
C20H18O2Sn (410.03287179999995)
D009676 - Noxae > D013723 - Teratogens D016573 - Agrochemicals Nonsystemic fungicid D010575 - Pesticides
Tanomastat
C23H19ClO3S (410.0743374000001)
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor D000970 - Antineoplastic Agents
7,11,12-Triacetoxycoumestan
Animal growth stimulan
(6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Tanomastat
C23H19ClO3S (410.0743374000001)
Quercetin 3,7-dimethyl ether 4-sulfate
C17H14O10S (410.03076640000006)
6-Hydroxyluteolin 6,3-dimethyl ether 7-sulfate
C17H14O10S (410.03076640000006)
6-Hydroxykaempferol 7,4-dimethyl ether 3-sulfate
C17H14O10S (410.03076640000006)
Eupalitin 3-O-sulfate
C17H14O10S (410.03076640000006)
Rhamnazin 3-O-sulfate
C17H14O10S (410.03076640000006)
3-[4-(4-Chlorobenzoyl)-1-methyl-1H-pyrrol-2-yl]-2-(phenylsulfonyl)acrylonitrile
C21H15ClN2O3S (410.0491870000001)
5-hydroxy-6,7,4-trimethoxyflavanone-5-sulfate
C18H18O9S (410.06714980000004)
cis-3-(6-Hydroxy-7-methoxy-5-benzofuranyl)acrylic acid glucuronide
Stimol 410
13-bromo-10R,11R-dichloro-7,11-dimethyl-3-methylene-4R-hydroxy-6E,8E,12E-tridecatrienoic acid
4-Ethoxy-3-(5-methyl-4-oxo-7-propyl-3,4-dihydro-imidazo[5,1-f][1,2,4]-triazin-2-yl)benzene-sulfonyl Chloride
C17H19ClN4O4S (410.08154840000003)
5μ-Inosinic acid hydrate disodium salt,I-5μ-P,IMP,Inosinic Acid
C10H13N4Na2O9P (410.02155380000005)
2-(4-((6-BROMO-3-NITROQUINOLIN-4-YL)AMINO)PHENYL)-2-METHYLPROPANENITRILE
Phosphonium,(3-methyl-2-buten-1-yl)triphenyl-, bromide (1:1)
(S)-tert-butyl 2-(5-(4-bromophenyl)-1h-imidazol-2-yl)pyrrolidine-1-carboxylate
Sodium 5-O-phosphonatoinosine hydrate (2:1:1)
C10H13N4Na2O9P (410.02155380000005)
2,9-dichloroquino[2,3-b]acridine-6,7,13,14(5H,12H)-tetrone
2,3,4,6-Tetra-O-acetyl-alpha-D-glucopyranosyl bromide
6-BROMOSPIRO[BENZO[E][1,3]OXAZINE-2,4-PIPERIDIN]-4(3H)-ONE 2,2,2-TRIFLUOROACETATE
C14H14BrF3N2O4 (410.00889800000004)
1,2,4-Benzenetricarboxylic acid 1,2-anhydride ethylene ester
[3-Formyl-4-(2-iodobenzyloxy)phenyl]acetic acid methyl ester
2,3,4,6-Tetra-O-acetyl-alpha-D-galactopyranosyl bromide
N-Desmethyl Zopiclone Hydrochloride
C16H16Cl2N6O3 (410.06608859999994)
3-(1h-imidazol-4-yl)propyl(4-bromophenyl)methyl ether, maleic acid
4-Ethoxy-3-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)benzene-1-sulfonyl chloride
C17H19ClN4O4S (410.08154840000003)
1H,1H,11H,11H-PERFLUORO-3,6,9-TRIOXAUNDECANE-1,11-DIOL
[4-(5-bromo-2-chloro-benzyl)-phenoxy]-tert-butyl-dimethyl-silane
N-methyl ,ethyl-Morpholinium bis((trifluoromethyl)sulfonyl)imide
mesityl(phenyl)iodonium tetrafluoroborate
C15H16BF4I (410.03258839999995)
2,3,4,6-TETRA-O-ACETYL-ALPHA-D-MANNOPYRANOSYL BROMIDE
2,3,4,6-TETRA-O-ACETYL-BETA-D-GLUCOPYRANOSYL BROMIDE
2-(3-bromophenyl)-6-[(2-hydroxyethyl)amino]-1H-benzo[de]isoquinoline-1,3(2H)-dione
C20H15BrN2O3 (410.02659800000004)
4-[4-(4-Chlorophenyl)phenyl]-4-oxo-2-(phenylsulfanylmethyl)butanoic acid
C23H19ClO3S (410.0743374000001)
2-[[2-methyl-5-nitro-3-(phenylmethyl)-4-imidazolyl]thio]-6-nitro-1H-benzimidazole
C18H14N6O4S (410.07972040000004)
3-Chloro-5-[2-Chloro-5-(1h-Pyrazolo[3,4-B]pyridin-3-Ylmethoxy)phenoxy]benzonitrile
4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid
ethyl 2-chloro-5-[5-[(E)-(5-cyano-4-methyl-2,6-dioxopyridin-3-ylidene)methyl]furan-2-yl]benzoate
C21H15ClN2O5 (410.06694500000003)
2-(4-Chlorophenyl)-2-oxoethyl 2,6-bis(trifluoromethyl)benzoate
C17H9ClF6O3 (410.01443859999995)
4-{[(E)-(3-bromo-4-hydroxy-5-methoxyphenyl)methylidene]amino}-5-cyclohexyl-2,4-dihydro-3H-1,2,4-triazole-3-thione
5-O-phosphono-2-deoxyribosyl-(3->5)-2-deoxyribose
A 2-deoxyribose bisphosphate that is 2-deoxy-alpha-D-ribofuranose 3,5-bisphosphate in which the phosphate group at position 3 is esterfied by a 2-deoxy-alpha-D-ribofuranos-5-yl group.
6-bromo-N-(3,4-dimethylphenyl)-3-oxo-4H-1,4-benzoxazine-7-sulfonamide
C16H15BrN2O4S (409.99358500000005)
[2-[(E)-(2-Amino-4-oxo-1,3-thiazol-5-ylidene)methyl]phenyl] naphthalene-2-sulfonate
3,4,5-Trihydroxy-6-[3-(4-methoxy-1-benzouran-5-yl)-3-oxopropanoyl]oxyoxane-2-carboxylic acid
6-[1-Carboxy-2-(4-methoxy-1-benzofuran-5-yl)-2-oxoethyl]-3,4,5-trihydroxyoxane-2-carboxylic acid
(R)-1,1-Dibromo-4-(tert-butyldimethylsilyloxy)-7-methyl-1,7-octadiene
Fentin acetate
C20H18O2Sn (410.03287179999995)
D009676 - Noxae > D013723 - Teratogens D016573 - Agrochemicals D010575 - Pesticides
Ceftibuten
A third-generation cephalosporin antibiotic with a [(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino substituent at the 7 position of the cephem skeleton. An orally-administered agent, ceftibuten is used as the dihydrate to treat urinary-tract and respiratory-tract infections. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
Butoconazole
C19H17Cl3N2S (410.0177972000001)
G - Genito urinary system and sex hormones > G01 - Gynecological antiinfectives and antiseptics > G01A - Antiinfectives and antiseptics, excl. combinations with corticosteroids > G01AF - Imidazole derivatives D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent
SIRT2/6-IN-1
C19H14N4O5S (410.06848740000004)
SIRT2/6-IN-1 (Compound 5) is a SIRT6/SIRT2 inhibitor, with IC50s of 106 μM and 114 μM. SIRT2/6-IN-1 increases H3K9 acetylation, increases glucose uptake and reduces TNF-α secretion in cells[1].